Skip to main content
NCBI home page
Heart logoLink to Heart
. 2000 Jul;84(1):106–112. doi: 10.1136/heart.84.1.106

Diagnosis and management of dilated cardiomyopathy

P Elliott 1
PMCID: PMC1729405  PMID: 10862601

Full Text

The Full Text of this article is available as a PDF (147.9 KB).

Figure 1:  .

Figure 1:  

Open in a new tab

Parasternal long axis (A) and apical four chamber (B) cross sectional (two dimensional) echocardiograms in a 23 year old patient with IDC.

Figure 2:  .

Figure 2:  

Open in a new tab

Myocardial section from a patient with IDC stained for the intercellular adhesion molecule 1 (ICAM-1) (green) and factor VIII (red). Dual staining in yellow indicates the presence of endothelial ICAM activity, indicative of chronic low grade inflammation. Reproduced with permission from Professor Michael Davies.       

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auricchio A., Stellbrink C., Block M., Sack S., Vogt J., Bakker P., Klein H., Kramer A., Ding J., Salo R. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation. 1999 Jun 15;99(23):2993–3001. doi: 10.1161/01.cir.99.23.2993. [DOI] [PubMed] [Google Scholar]
  2. Baboonian C., Treasure T. Meta-analysis of the association of enteroviruses with human heart disease. Heart. 1997 Dec;78(6):539–543. doi: 10.1136/hrt.78.6.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Deswal A., Bozkurt B., Seta Y., Parilti-Eiswirth S., Hayes F. A., Blosch C., Mann D. L. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation. 1999 Jun 29;99(25):3224–3226. doi: 10.1161/01.cir.99.25.3224. [DOI] [PubMed] [Google Scholar]
  4. Doval H. C., Nul D. R., Grancelli H. O., Perrone S. V., Bortman G. R., Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) Lancet. 1994 Aug 20;344(8921):493–498. doi: 10.1016/s0140-6736(94)91895-3. [DOI] [PubMed] [Google Scholar]
  5. Massie B. M., Fisher S. G., Radford M., Deedwania P. C., Singh B. N., Fletcher R. D., Singh S. N. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators. Circulation. 1996 Jun 15;93(12):2128–2134. doi: 10.1161/01.cir.93.12.2128. [DOI] [PubMed] [Google Scholar]
  6. McCarthy J. F., McCarthy P. M., Starling R. C., Smedira N. G., Scalia G. M., Wong J., Kasirajan V., Goormastic M., Young J. B. Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure. Eur J Cardiothorac Surg. 1998 Apr;13(4):337–343. doi: 10.1016/s1010-7940(98)00013-x. [DOI] [PubMed] [Google Scholar]
  7. McKelvie R. S., Yusuf S., Pericak D., Avezum A., Burns R. J., Probstfield J., Tsuyuki R. T., White M., Rouleau J., Latini R. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. Circulation. 1999 Sep 7;100(10):1056–1064. doi: 10.1161/01.cir.100.10.1056. [DOI] [PubMed] [Google Scholar]
  8. McNamara D. M., Rosenblum W. D., Janosko K. M., Trost M. K., Villaneuva F. S., Demetris A. J., Murali S., Feldman A. M. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation. 1997 Jun 3;95(11):2476–2478. doi: 10.1161/01.cir.95.11.2476. [DOI] [PubMed] [Google Scholar]
  9. Mestroni L., Maisch B., McKenna W. J., Schwartz K., Charron P., Rocco C., Tesson F., Richter A., Wilke A., Komajda M. Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J. 1999 Jan;20(2):93–102. doi: 10.1053/euhj.1998.1145. [DOI] [PubMed] [Google Scholar]
  10. Noutsias M., Seeberg B., Schultheiss H. P., Kühl U. Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation. 1999 Apr 27;99(16):2124–2131. doi: 10.1161/01.cir.99.16.2124. [DOI] [PubMed] [Google Scholar]
  11. Packer M., Bristow M. R., Cohn J. N., Colucci W. S., Fowler M. B., Gilbert E. M., Shusterman N. H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996 May 23;334(21):1349–1355. doi: 10.1056/NEJM199605233342101. [DOI] [PubMed] [Google Scholar]
  12. Packer M., Poole-Wilson P. A., Armstrong P. W., Cleland J. G., Horowitz J. D., Massie B. M., Rydén L., Thygesen K., Uretsky B. F. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation. 1999 Dec 7;100(23):2312–2318. doi: 10.1161/01.cir.100.23.2312. [DOI] [PubMed] [Google Scholar]
  13. Pitt B., Segal R., Martinez F. A., Meurers G., Cowley A. J., Thomas I., Deedwania P. C., Ney D. E., Snavely D. B., Chang P. I. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) Lancet. 1997 Mar 15;349(9054):747–752. doi: 10.1016/s0140-6736(97)01187-2. [DOI] [PubMed] [Google Scholar]
  14. Pitt B., Zannad F., Remme W. J., Cody R., Castaigne A., Perez A., Palensky J., Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999 Sep 2;341(10):709–717. doi: 10.1056/NEJM199909023411001. [DOI] [PubMed] [Google Scholar]
  15. Rose E. A., Moskowitz A. J., Packer M., Sollano J. A., Williams D. L., Tierney A. R., Heitjan D. F., Meier P., Ascheim D. D., Levitan R. G. The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg. 1999 Mar;67(3):723–730. doi: 10.1016/s0003-4975(99)00042-9. [DOI] [PubMed] [Google Scholar]
  16. Sliwa K., Skudicky D., Candy G., Wisenbaugh T., Sareli P. Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy. Lancet. 1998 Apr 11;351(9109):1091–1093. doi: 10.1016/S0140-6736(97)09338-0. [DOI] [PubMed] [Google Scholar]
  17. Torp-Pedersen C., Møller M., Bloch-Thomsen P. E., Køber L., Sandøe E., Egstrup K., Agner E., Carlsen J., Videbaek J., Marchant B. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med. 1999 Sep 16;341(12):857–865. doi: 10.1056/NEJM199909163411201. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Additional references]
heart_84_1_106__index.html (3.7KB, html)

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES